Sommetrics

18 articles with Sommetrics

• Sommetrics Receives FDA Breakthrough Device Designation for Its aerSleep II Product to Treat Sleep Apnea

  11/17/2020

  Sommetrics , a private company developing products and services to improve sleep health, today announced its lead sleep apnea product, aerSleep II, has received FDA Breakthrough Device designation. This program allows for additional FDA feedback to sponsors during the pre-marketing phase but does not alter the basic requirements for market authorization. The Breakthrough Device program is intended to help patients gain mo

• Sommetrics Requests Emergency Use Authorization to Introduce Its aerSleep Product for Sleep Apnea Patients at Risk of COVID-19

  6/23/2020

  Sommetrics , Inc., a company providing products and services to improve sleep quality, announced it filed an application with the FDA for Emergency Use Authorization to introduce its aerSleep® II product to treat obstructive sleep apnea in people at risk of COVID-19. The intent is to reduce transmission of SARS-CoV-2 by those with documented or suspected infection by replacing CPAP therapy for sleep apnea with aerSleep® I

• Sommetrics Receives ISO 13485:2016 Certification

  5/19/2020

  Sommetrics , Inc., which provides products to treat airway obstruction during sleep and in acute care settings, announced today that its quality management system has been certified to the rigorous ISO 13485:2016 standard. During the audit process required for certification, Sommetrics was also evaluated and found to be in compliance with the standards of the Medical Device Single Audit Program (MDSAP) for Canada. “This is

• Sommetrics and aerFree, LLC Contributing to Treatment of COVID-19

  5/13/2020

  Sommetrics , Inc. a company providing products and services to improve sleep quality, and its partially owned affiliate, aerFree, LLC, which is dedicated to improving acute airway management, today announced the donation of their aerFree® product to leading academic centers to assist in the management of COVID-19 respiratory impairment. aerFree® is a FDA cleared, single use product intended to maintain the patency of the u

• Sommetrics Completes Study of New Sleep Apnea Treatment in Ethnic Japanese Subjects

  6/25/2019

  Sommetrics, a company dedicated to developing state of the art products to treat obstructive sleep apnea (OSA), today announced the completion of clinical study SOM-014

• Sommetrics Chosen as a 2019 Red Herring Top 100 North America Winner

  5/23/2019

  Sommetrics announced that they have been named as one of the winners of Red Herring’s 2019 Top 100 North America, recognizing the continent’s most exciting and innovative private technology companies.

• Sommetrics Selected to Participate in Red Herring Top 100 Competition

  5/7/2019

  Sommetrics announced it has been selected to participate in the annual Red Herring Top 100 competition in Los Angeles on May 15, 2019.

• Former Inogen CEO, Ray Huggenberger, Joins Ebb Therapeutics Board of Directors

  9/18/2018

  Ebb Therapeutics announces that its added Ray Huggenberger to its Board of Directors.

• Sommetrics Awarded Frost & Sullivan 2018 Visionary Innovation Leadership Award for Acute Airway Management

  7/17/2018

  Sommetrics announced that it has been awarded the Frost & Sullivan 2018 Visionary Innovation Leadership Award for Acute Airway Management.

• Industry Leader David Schlotterbeck Joins the Sommetrics Advisory Board

  6/12/2018

  Sommetrics today announced it has added industry leader David Schlotterbeck to its advisory board.

• Renowned Sleep Expert Dr. Jerrold Kram to Present New Sleep Apnea Treatment by Sommetrics at SLEEP 2018

  5/30/2018

  Sommetrics announced that renowned sleep expert Jerrold Kram, M.D., FCCP, FAASM, will be discussing the company’s new sleep apnea treatment, aerSleepTM, during SLEEP 2018, the 32nd Annual Meeting of the Associated Professional Sleep Societies in Baltimore, Maryland.

• Sommetrics Adds Prominent Healthcare Leaders to Board of Directors and Advisory Board

  11/30/2017

  The company also recently engaged Key West Investments to help raise additional capital to support the development and commercialization of products and services to treat disorders of the upper airway, such as obstructive sleep apnea and snoring.

• Sommetrics Partners With AvantSleep to Market Novel Sleep Apnea Solution in Canada

  11/7/2017

  AvantSleep will distribute aerSleep in select Canadian markets, followed by a full Canadian launch in 2018.

• Sommetrics Engages Key West Investments to Raise Additional Capital, Prepares for Commercialization of Sleep Apnea Therapy

  10/24/2017

  Sommetrics today announced that it has engaged Key West Investments to help raise additional capital. This capital will support the company’s development and commercialization of products to treat disorders of the upper airway such as obstructive sleep apnea and chronic snoring.

• Smiths Medical And Sommetrics Sign Distribution Agreement For New Airway Management System

  9/12/2017

• Sommetrics Expands Board Of Directors And Management Team To Prepare For Canadian Launch Of New Sleep Apnea Therapy

  7/18/2017

• Sommetrics Receives Health Canada Approval To Market New Sleep Apnea Therapy

  6/21/2017

• SoCal's Sommetrics Rakes in $12.3 Million

  4/10/2017